Interventions to prevent and treat multiple long-term conditions and their consequences across the life course: concepts and definitions

Multiple long-term conditions (MLTC; also known as multimorbidity) constitute an important unmet health challenge. Designing and evaluating interventions to prevent and treat MLTC and their consequences is essential but difficult, due to heterogeneous risk factors, biological mechanisms, condition combinations, social and functional impacts of MLTC. To make progress, shared ways of describing and discussing interventions to prevent and treat MLTC and their consequences would bring consistency and clarity to this complex research area.In this position paper, we aim to provide a framework to address this recently articulated need. We propose a conceptual framework for placing MLTC interventions on a spectrum of prevention and treatment (from primordial to quaternary prevention). We consider different key intervention time points across the life course and how the focus of interventions may change from reducing risk factors in earlier life, through prevention of condition accumulation or progression in later life, to mitigating adverse consequences on symptoms and function as conditions progress. We propose taxonomies of interventions based on simple description but also on the existing World Health Organisation International Classification of Health Interventions taxonomy. We discuss principles of intervention development, focussing particularly on the need to target shared biological mechanisms and risk factors rather than attempting to treat or prevent each condition individually, and focussing on symptoms or consequences of MLTC that are prioritised by patients.Finally, we consider the attributes of effective MLTC interventions; we argue that ideal interventions should have robust evidence of efficacy and effectiveness, should be scalable and implementable within existing health and social care systems, should reduce (or at least not increase) health inequality, should be cost-effective, and should deliver major improvements over and above existing interventions, either at individual or population level. We recommend using this conceptual framework, taxonomy and criteria for assessing interventions together to organise the planning and evaluation of MLTC intervention research thereby accelerating progress in this important yet understudied field.

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2026-04-10
DOI
https://doi.org/10.1186/s12916-026-04838-4
Primary Topic
Chronic Disease Management Strategies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interventions to prevent and treat multiple long-term conditions and their consequences across the life course: concepts and definitions

Nira Shah, Claire McDonald, Michelle Collinson, Farheen Yameen et al.
BMC Medicine
Chronic Disease Management Strategies
article

Interventions to prevent and treat multiple long-term conditions and their consequences across the life course: concepts and definitions

Nira Shah, Claire McDonald, Michelle Collinson, Farheen Yameen, Guruprasad Padur Aithal, Stephanie J. C. Taylor, Lily Yao, Avan A. Sayer, Andrew Farmer, Sarah E. Lamb, Kamlesh Khunti, Rachel Cooper, Krishnarajah Nirantharakumar, Miles D. Witham, James P. Sheppard, Peter Hanlon, Sally J. Singh, Melanie J. Davies, Simon D.S. Fraser
article en

Abstract

Multiple long-term conditions (MLTC; also known as multimorbidity) constitute an important unmet health challenge. Designing and evaluating interventions to prevent and treat MLTC and their consequences is essential but difficult, due to heterogeneous risk factors, biological mechanisms, condition combinations, social and functional impacts of MLTC. To make progress, shared ways of describing and discussing interventions to prevent and treat MLTC and their consequences would bring consistency and clarity to this complex research area.In this position paper, we aim to provide a framework to address this recently articulated need. We propose a conceptual framework for placing MLTC interventions on a spectrum of prevention and treatment (from primordial to quaternary prevention). We consider different key intervention time points across the life course and how the focus of interventions may change from reducing risk factors in earlier life, through prevention of condition accumulation or progression in later life, to mitigating adverse consequences on symptoms and function as conditions progress. We propose taxonomies of interventions based on simple description but also on the existing World Health Organisation International Classification of Health Interventions taxonomy. We discuss principles of intervention development, focussing particularly on the need to target shared biological mechanisms and risk factors rather than attempting to treat or prevent each condition individually, and focussing on symptoms or consequences of MLTC that are prioritised by patients.Finally, we consider the attributes of effective MLTC interventions; we argue that ideal interventions should have robust evidence of efficacy and effectiveness, should be scalable and implementable within existing health and social care systems, should reduce (or at least not increase) health inequality, should be cost-effective, and should deliver major improvements over and above existing interventions, either at individual or population level. We recommend using this conceptual framework, taxonomy and criteria for assessing interventions together to organise the planning and evaluation of MLTC intervention research thereby accelerating progress in this important yet understudied field.

BMC MedicineVol. 24(1)
University of Leeds (GB), University of Leicester (GB), Queen Mary University of London (GB), King's College London (GB), University of Exeter (GB), Cumbria Northumberland Tyne and Wear NHS Foundation Trust (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), University of Oxford (GB), NIHR Exeter Clinical Research Facility (GB), NIHR Newcastle Biomedical Research Centre (GB), Oxford BioMedica (United Kingdom) (GB), Nottingham Biomedical Research Centre (GB), NIHR Research Delivery Network (GB), NIHR Leicester Biomedical Research Centre (GB), University of Southampton (GB), University of Glasgow (GB), Newcastle University (GB)
National Institute for Health and Care Research, British Heart Foundation, NIHR Newcastle Biomedical Research Centre, NIHR Oxford Biomedical Research Centre, NIHR Leicester Biomedical Research Centre
Openalex Percentile: Top 25%
Chronic Disease Management Strategies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.